Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bushra M. Alghamdi"'
Autor:
Yazed S. Alruthia, Monira Alwhaibi, Mashal F. Alotaibi, Shatha A. Asiri, Bushra M. Alghamdi, Ghadah S. Almuaythir, Wejdan R. Alsharif, Hala H. Alrasheed, Yahya A. Alswayeh, Abdulaziz J. Alotaibi, Mohammad Almeshal, Saleh N. Aldekhail, Abdulrahman Alhusaini, Sulaiman A. Alrashed, Ali M. Alrumaih, Mohammed A. Dahhas, Mohammed A. Alghamdi, Mohammad S. Aleheidib, Mohamed H. Alhaidari, Jameel A. Alharbi, Aws Alshamsan
Publikováno v:
Saudi Pharmaceutical Journal, Vol 26, Iss 7, Pp 947-951 (2018)
Drug shortages are a multifaceted problem that has been recurring in Saudi Arabia over the past decade with its significant negative impact on patient care. However, there is a dearth of evidence about possible domestic reasons, if any, behind this r
Externí odkaz:
https://doaj.org/article/3d18431b6d16479a808837ce86aa7992
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Introduction Repeat prescription refers to a re-prescribed medications list issued by a refill clinic, commonly for stable chronic illnesses. The issues regarding repeat prescriptions have garnered increasing important in recent years, as no general
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db21f7d6171ab88737497e0c5e496998
http://europepmc.org/articles/PMC8596148
http://europepmc.org/articles/PMC8596148
Autor:
Rawan Alenazi, Shatha Asiri, Saja Almazrou, Wejdan R. Alsharif, Badr Aljohani, Ghadah S. Almuaythir, Yazed AlRuthia, Hala H. Alrasheed, Bushra M. Alghamdi, Maryam Alarfaj, Ahmed L. Alaofi, Omar Almazroo
Publikováno v:
Health Policy and Technology. 10:120-125
Background The recent incidents of generic drug recalls have shaken the public confidence in the quality of generic drugs in Saudi Arabia. Therefore, many clinicians and health policymakers are calling for the establishment of a national reference or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90953dba4a38dccaabbffec6e8c50acd
https://doi.org/10.1016/j.hlpt.2020.08.018
https://doi.org/10.1016/j.hlpt.2020.08.018
Autor:
Ghadah S. Almuaythir, Wejdan R. Alsharif, Sultan Alghadeer, Hala H. Alrasheed, Azher Arafah, Reem Alhaider, Fahad D. Alosaimi, Khalid Alsaleh, Yazed AlRuthia, Bushra M. Alghamdi, Shatha Asiri
Publikováno v:
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal, Vol 27, Iss 6, Pp 859-865 (2019)
Saudi Pharmaceutical Journal, Vol 27, Iss 6, Pp 859-865 (2019)
Background: Multiple scales in different languages were developed to measure patient-reported side effects of antineoplastics. However, these scales vary in their coverage of antineoplastics’ side effects, and none of them address both the severity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a7310af901d3edfa84482f5cb744874
https://pubmed.ncbi.nlm.nih.gov/31516328
https://pubmed.ncbi.nlm.nih.gov/31516328